DNAprint Genomics (DNAG)

[frogdreaming]

Bag8ger, The dilemma will always exist, only the weighting factors can change. It is simplistic to assume that even 'IF' DNAP could create effective classifiers, then the problem would go away. If anything it would add to the problem.

Effective drugs are being pilloried because of certain low levels of adverse side effects. DNAP could obviously reduce the occurence of the effect by developing effective classifiers. They will NOT eliminate them, their own data shows a certain level of effectiveness but it is NOT 100%. Some people will still die.

Carry the concept to the next level. What happens when a drug is developed that absolutely cures a major disease (lung cancer, diabetes or heart disease) but it's side effects kill 50% of it's patients. If DNAP can reduce that effect to 1% will that be good enough? 0.5% ? 0.001? Where will you put the limit?

Like I said the hard decisions will still need to be made. DNAP may be able to help with the trend toward safety but only an idiot would expect them to 'resolve' the problem.